$GWPH $144.70
June 25, 2018
3:28 pm ET
UPDATE: Investors are making stoner moves by buying marijuana stocks at the wrong time
MarketWatch
3:26 pm ET
FDA Approves First Drug Derived From Marijuana Plant
Dow Jones
2:40 pm ET
Update: First U.S. Cannabis-derived Drug Has Been Approved By The FDA -- MarketWatch
MarketWatch
2:40 pm ET
UPDATE: First U.S. cannabis-derived drug has been approved by the FDA
MarketWatch
2:40 pm ET
The first cannabis-derived drug was just approved in the U.S.
MarketWatch
2:00 pm ET
The Week Ahead: Senate Weighs Sprint-T-Mobile Merger, Nike Earnings And A Slew Of IPOs
Benzinga
1:21 pm ET
*Downside In GW Pharma Intensifies As $150 Level Breaks Down; Shares Down 2% Over Last Few Mins., Stock Now Down 2.7% For Session
Benzinga
1:17 pm ET
FDA Comments on Approval of Cannabis-Derived Drug, Which GW Pharmaceuticals Announced Earlier Monday
Dow Jones
1:12 pm ET
First U.S. cannabis-derived drug has been approved by the FDA
MarketWatch
1:12 pm ET
First U.S. Cannabis-derived Drug Has Been Approved By The FDA -- MarketWatch
MarketWatch
1:06 pm ET
GW Pharma's Epidiolex Becomes First Cannabis-Based FDA-Approved Drug
Benzinga
1:03 pm ET
'$GWPH says it will take @DEAHQ "within 90 days" to schedule Epidiolex, so drug could go on sale this fall'-WSJ's Jonathan Rockoff Tweets
Benzinga
12:58 pm ET
First U.S. cannabis-derived drug has been approved by the FDA
MarketWatch
12:57 pm ET
GW Pharmaceuticals plc and its U.S. Subsidiary Greenwich Biosciences Announce FDA Approval of EPIDIOLEX(R) (cannabidiol) oral solution - the First Plant-derived Cannabinoid Prescription Medicine
Globe Newswire
12:47 pm ET
'FDA sends pre-emptive warning to anyone trying to peddle unapproved uses of medical marijuana or cannabidiol, now that $GWPH approved @SGottliebFDA statement'-STAT's Adam Feuerstein Tweets
Benzinga
12:43 pm ET
BZ NOTE: Despite FDA Approval For GW Pharma's Epidiolex, Before Co. Can Market Epidiolex The U.S. DEA Will Have To Reclassify Cannabidiol
Benzinga
12:33 pm ET
GW Pharma Shares Now At New Session Low, Down 1.4% For Session; Shares Initially Spiked 5% As Traders First Circulated FDA.gov Doc Showing Approval For Epidiolex In Dravet Syndrome
Benzinga
12:27 pm ET
*BZ NOTE: Watch Shares of Cannabinoid Peer Zynerba Pharma Amid FDA Approval For GW Pharma's Epidiolex
Benzinga
12:25 pm ET
GW Pharma Receives FDA Approval Of NDA For Epidiolex
Benzinga
11:06 am ET
Investors are making stoner moves by buying marijuana stocks at the wrong time
MarketWatch
5:12 am ET
*REMINDER Stocks With FDA Actions Expected This Week Include: Achaogen PDUFA Date for Plazomicin 6/25, Durect and Pain Therapeutics AdCom For Remoxy June 26, & GW Pharma PDUFA For Epidiolex in LG Syndrome June 27
Benzinga
June 25, 2018
3:28 pm ET
UPDATE: Investors are making stoner moves by buying marijuana stocks at the wrong time
MarketWatch
3:26 pm ET
FDA Approves First Drug Derived From Marijuana Plant
Dow Jones
2:40 pm ET
Update: First U.S. Cannabis-derived Drug Has Been Approved By The FDA -- MarketWatch
MarketWatch
2:40 pm ET
UPDATE: First U.S. cannabis-derived drug has been approved by the FDA
MarketWatch
2:40 pm ET
The first cannabis-derived drug was just approved in the U.S.
MarketWatch
2:00 pm ET
The Week Ahead: Senate Weighs Sprint-T-Mobile Merger, Nike Earnings And A Slew Of IPOs
Benzinga
1:21 pm ET
*Downside In GW Pharma Intensifies As $150 Level Breaks Down; Shares Down 2% Over Last Few Mins., Stock Now Down 2.7% For Session
Benzinga
1:17 pm ET
FDA Comments on Approval of Cannabis-Derived Drug, Which GW Pharmaceuticals Announced Earlier Monday
Dow Jones
1:12 pm ET
First U.S. cannabis-derived drug has been approved by the FDA
MarketWatch
1:12 pm ET
First U.S. Cannabis-derived Drug Has Been Approved By The FDA -- MarketWatch
MarketWatch
1:06 pm ET
GW Pharma's Epidiolex Becomes First Cannabis-Based FDA-Approved Drug
Benzinga
1:03 pm ET
'$GWPH says it will take @DEAHQ "within 90 days" to schedule Epidiolex, so drug could go on sale this fall'-WSJ's Jonathan Rockoff Tweets
Benzinga
12:58 pm ET
First U.S. cannabis-derived drug has been approved by the FDA
MarketWatch
12:57 pm ET
GW Pharmaceuticals plc and its U.S. Subsidiary Greenwich Biosciences Announce FDA Approval of EPIDIOLEX(R) (cannabidiol) oral solution - the First Plant-derived Cannabinoid Prescription Medicine
Globe Newswire
12:47 pm ET
'FDA sends pre-emptive warning to anyone trying to peddle unapproved uses of medical marijuana or cannabidiol, now that $GWPH approved @SGottliebFDA statement'-STAT's Adam Feuerstein Tweets
Benzinga
12:43 pm ET
BZ NOTE: Despite FDA Approval For GW Pharma's Epidiolex, Before Co. Can Market Epidiolex The U.S. DEA Will Have To Reclassify Cannabidiol
Benzinga
12:33 pm ET
GW Pharma Shares Now At New Session Low, Down 1.4% For Session; Shares Initially Spiked 5% As Traders First Circulated FDA.gov Doc Showing Approval For Epidiolex In Dravet Syndrome
Benzinga
12:27 pm ET
*BZ NOTE: Watch Shares of Cannabinoid Peer Zynerba Pharma Amid FDA Approval For GW Pharma's Epidiolex
Benzinga
12:25 pm ET
GW Pharma Receives FDA Approval Of NDA For Epidiolex
Benzinga
11:06 am ET
Investors are making stoner moves by buying marijuana stocks at the wrong time
MarketWatch
5:12 am ET
*REMINDER Stocks With FDA Actions Expected This Week Include: Achaogen PDUFA Date for Plazomicin 6/25, Durect and Pain Therapeutics AdCom For Remoxy June 26, & GW Pharma PDUFA For Epidiolex in LG Syndrome June 27
Benzinga
